NEUP

MKT CAP:$27M

Neuphoria Therapeutics Inc.

Market Cap

$27M

Healthcare·Medical - Pharmaceuticals·🇺🇸 United States·NASDAQ

Healthcare·Medical·🇺🇸·NASDAQ

Stock Price

$4.87+$1.05 (+27.49%)

Apr 21, 2026

Company Details

Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company was founded on December 23, 2024 and ...

CEO

Spyridon Papapetropoulos

IPO Date

Dec 16, 2021

Website

www.neuphoriatx.com

Key Metrics TTM

Revenue

$0

— YoY

Net Income

$2M

EPS (Diluted)

-$1.15

Free Cash Flow

-$6M

Revenue / Share

$0.00

Gross Margin

—

Operating Margin

—

Net Margin

—

FCF Margin

—

P/S

—

P/E

14.2x

Earnings Reports

FY 2026

Feb 17, 2026

$0EPS $0.41

Q2 2026

Feb 17, 2026

$0EPS -$1.15

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q2 26	$0	-$248.4K	-$4M

Operating Cash Flow

Quarter	Operating CF	Free CF
Q3 20	-$907.3K	-$907.3K
Q4 20	-$1M	-$1M
Q1 21	-$2M	-$2M
Q2 21	$667.1K	$667.1K
Q3 21	-$1M	-$1M
Q4 21	-$2M	-$2M
Q1 22	-$3M	-$3M
Q2 22	-$4M	-$4M
Q3 22	-$2M	-$2M
Q4 22	$0	-$3M
Q1 23	-$2M	-$2M
Q2 23	$0	$0
Q3 23	-$4M	-$4M
Q4 23	$0	-$2M
Q4 25	$74M	$74M
Q2 26	-$6M	-$6M

Capital Expenditures

Quarter	CapEx
Q3 20	$0
Q4 20	$0
Q1 21	$0
Q2 21	$0
Q3 21	$0
Q4 21	$0
Q1 22	$0
Q2 22	$0
Q3 22	$0
Q4 22	$0
Q1 23	$0
Q2 23	$0
Q3 23	$0
Q4 23	$0
Q4 25	$3
Q2 26	$0

CapEx

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q3 20	$0	—
Q4 20	$0	—
Q1 21	$0	—
Q2 21	$0	—
Q3 21	$0	—
Q4 21	$0	—
Q1 22	$0	—
Q2 22	$0	—
Q3 22	$0	—
Q4 22	$0	—
Q1 23	$0	—
Q2 23	$0	—
Q3 23	$0	—
Q4 23	$0	—
Q4 25	$164M	—
Q2 26	$93.7K	—

OpEx Breakdown

Quarter	R&D	G&A
Q2 26	$697.7K	$2M

War Chest

Quarter	Cash	Short-term Investments	Total
Q3 22	$24M	$0	$24M
Q4 22	$23M	$0	$23M
Q1 23	$22M	$0	$22M
Q2 23	$15M	$0	$15M
Q3 23	$13M	$0	$13M
Q4 23	$13M	$0	$13M
Q1 24	$6M	$0	$6M
Q2 24	$11M	$0	$11M
Q3 24	$0	$0	$0
Q4 24	$13M	$0	$13M
Q1 25	$8M	$0	$8M
Q2 25	$4M	$0	$4M
Q3 25	$17M	$0	$17M
Q4 25	$22M	$0	$22M
Q1 26	$14M	$0	$14M
Q2 26	$22M	$0	$22M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q2 26	5M	—	—

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q2 26	$0	7

Revenue / Employee